Losartan + Sunitinib in Treatment of Osteosarcoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Osteosarcoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: Dose escalation for Phase 1 with dose levels described in Arms and interventions.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 10 years and 40 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03900793
- Collaborators
- National Cancer Institute (NCI)
- Investigators
- Principal Investigator: Carrye Cost, MD Children's Hospital Colorado
Get Well Soon